Explore the vast range of titles available.

Background Slowed clearance of amyloid β (Aβ) is believed to underlie the development of Aβ plaques that characterize Alzheimer’s disease (AD). Aβ is cleared in part by the glymphatic system, a brain-wide network of perivascular pathways that supports the exchange of cerebrospinal and brain interstitial fluid. Glymphatic clearance, or perivascular CSF-interstitial fluid exchange, is dependent on the astroglial water channel aquaporin-4 (AQP4) as deletion of Aqp4 in mice slows perivascular exchange, impairs Aβ clearance, and promotes Aβ plaque formation. Methods To define the role of AQP4 in human AD, we evaluated AQP4 expression and localization in a human post mortem case series. We then used the α-syntrophin ( Snta1 ) knockout mouse model which lacks perivascular AQP4 localization to evaluate the effect that loss of perivascular AQP4 localization has on glymphatic CSF tracer distribution. Lastly, we crossed this line into a mouse model of amyloidosis (Tg2576 mice) to evaluate the effect of AQP4 localization on amyloid β levels. Results In the post mortem case series, we observed that the perivascular localization of AQP4 is reduced in frontal cortical gray matter of subjects with AD compared to cognitively intact subjects. This decline in perivascular AQP4 localization was associated with increasing Aβ and neurofibrillary pathological burden, and with cognitive decline prior to dementia onset. In rodent studies, Snta1 gene deletion slowed CSF tracer influx and interstitial tracer efflux from the mouse brain and increased amyloid β levels. Conclusions These findings suggest that the loss of perivascular AQP4 localization may contribute to the development of AD pathology in human populations.

Background Slowed clearance of amyloid [beta] (A[beta]) is believed to underlie the development of A[beta] plaques that characterize Alzheimer's disease (AD). A[beta] is cleared in part by the glymphatic system, a brain-wide network of perivascular pathways that supports the exchange of cerebrospinal and brain interstitial fluid. Glymphatic clearance, or perivascular CSF-interstitial fluid exchange, is dependent on the astroglial water channel aquaporin-4 (AQP4) as deletion of Aqp4 in mice slows perivascular exchange, impairs A[beta] clearance, and promotes A[beta] plaque formation. Methods To define the role of AQP4 in human AD, we evaluated AQP4 expression and localization in a human post mortem case series. We then used the [alpha]-syntrophin (Snta1) knockout mouse model which lacks perivascular AQP4 localization to evaluate the effect that loss of perivascular AQP4 localization has on glymphatic CSF tracer distribution. Lastly, we crossed this line into a mouse model of amyloidosis (Tg2576 mice) to evaluate the effect of AQP4 localization on amyloid [beta] levels. Results In the post mortem case series, we observed that the perivascular localization of AQP4 is reduced in frontal cortical gray matter of subjects with AD compared to cognitively intact subjects. This decline in perivascular AQP4 localization was associated with increasing A[beta] and neurofibrillary pathological burden, and with cognitive decline prior to dementia onset. In rodent studies, Snta1 gene deletion slowed CSF tracer influx and interstitial tracer efflux from the mouse brain and increased amyloid [beta] levels. Conclusions These findings suggest that the loss of perivascular AQP4 localization may contribute to the development of AD pathology in human populations. Keywords: Alzheimer's disease, Aquaporin-4, AQP4, [alpha]-Syntrophin, glymphatic, Amyloid [beta], Perivascular, Astrocyte

The glymphatic system is a recently defined brain-wide network of perivascular spaces along which cerebrospinal fluid (CSF) and interstitial solutes exchange. Astrocyte endfeet encircling the perivascular space form a physical barrier in between these two compartments, and fluid and solutes that are not taken up by astrocytes move out of the perivascular space through the junctions in between astrocyte endfeet. However, little is known about the anatomical structure and the physiological roles of the astrocyte endfeet in regulating the local perivascular exchange. Here, visualizing astrocyte endfoot-endfoot junctions with immunofluorescent labeling against the protein megalencephalic leukoencephalopathy with subcortical cysts-1 (MLC1), we characterized endfoot dimensions along the mouse cerebrovascular tree. We observed marked heterogeneity in endfoot dimensions along vessels of different sizes, and of different types. Specifically, endfoot size was positively correlated with the vessel diameters, with large vessel segments surrounded by large endfeet and small vessel segments surrounded by small endfeet. This association was most pronounced along arterial, rather than venous segments. Computational modeling simulating vascular trees with uniform or varying endfeet dimensions demonstrates that varying endfoot dimensions maintain near constant perivascular-interstitial flux despite correspondingly declining perivascular pressures along the cerebrovascular tree through the cortical depth. These results describe a novel anatomical feature of perivascular astroglial endfeet and suggest that endfoot heterogeneity may be an evolutionary adaptation to maintain perivascular CSF-interstitial fluid exchange through deep brain structures. Competing Interest Statement The authors have declared no competing interest.

Summary Bacillus subtilis GLB191 (hereafter GLB191) is an efficient biological control agent against the biotrophic oomycete Plasmopara viticola, the causal agent of grapevine downy mildew. In this study, we show that GLB191 supernatant is also highly active against downy mildew and that the activity results from both direct effect against the pathogen and stimulation of the plant defences (induction of defence gene expression and callose production). High‐performance thin‐layer chromatography analysis revealed the presence of the cyclic lipopeptides fengycin and surfactin in the supernatant. Mutants affected in the production of fengycin and/or surfactin were thus obtained and allowed us to show that both surfactin and fengycin contribute to the double activity of GLB191 supernatant against downy mildew. Altogether, this study suggests that GLB191 supernatant could be used as a new biocontrol product against grapevine downy mildew.

Phosphatidylinositol 3-kinase α, a heterodimer of catalytic p110α and one of five regulatory subunits, mediates insulin- and insulin like growth factor-signaling and, frequently, oncogenesis. Cellular levels of the regulatory p85α subunit are tightly controlled by regulated proteasomal degradation. In adipose tissue and growth plates, failure of K48-linked p85α ubiquitination causes diabetes, lipodystrophy and dwarfism in mice, as in humans with SHORT syndrome. Here we elucidated the structures of the key ubiquitin ligase complexes regulating p85α availability. Specificity is provided by the substrate receptor KBTBD2, which recruits p85α to the cullin3–RING E3 ubiquitin ligase (CRL3). CRL3 KBTBD2 forms multimers, which disassemble into dimers upon substrate binding (CRL3 KBTBD2 –p85α) and/or neddylation by the activator NEDD8 (CRL3 KBTBD2 ~N8), leading to p85α ubiquitination and degradation. Deactivation involves dissociation of NEDD8 mediated by the COP9 signalosome and displacement of KBTBD2 by the inhibitor CAND1. The hereby identified structural basis of p85α regulation opens the way to better understanding disturbances of glucose regulation, growth and cancer. Here, upon obtaining cryo-EM structures of CRL3 KBTBD2 in seven states, the authors propose a model for the activation cycle of CRL3 ligases, including assembly, substrate recruitment, (de)neddylation and CAND1-mediated substrate receptor exchange.

Epithelial cancers are believed to originate from transformation of tissue stem cells. However, bone marrow-derived cells (BMDCs), which are frequently recruited to sites of tissue injury and inflammation, might also represent a potential source of malignancy. We show that although acute injury, acute inflammation, or transient parietal cell loss within the stomach do not lead to BMDC recruitment, chronic infection of C57BL/6 mice with Helicobacter, a known carcinogen, induces repopulation of the stomach with BMDCs. Subsequently, these cells progress through metaplasia and dysplasia to intraepithelial cancer. These findings suggest that epithelial cancers can originate from marrow-derived sources and thus have broad implications for the multistep model of cancer progression.

BTEX (benzene, toluene, ethylbenzene, and m-xylene,p-xylene, and o-xylene) are significant urban air pollutants. This study examines BTEX variability across 7 European countries using data from 22 monitoring sites in different urban settings (urban background, traffic, industry, and suburban background). Results indicate that the relative abundance of BTEX in urban areas follows the order toluene > benzene > m,p-xylene > o-xylene > ethylbenzene, with median mixing ratios of 266 ± 152, 163 ± 74, 129 ± 88, 53 ± 35, and 45 ± 27 ppt during the years 2017–2022, respectively. Seasonal trends show benzene had similar median concentrations across urban background, traffic, and industrial sites, indicating mixed sources. Toluene levels were highest in traffic and industrial areas, highlighting road traffic and industrial emissions. Ethylbenzene and xylenes showed equivalent levels in traffic and industrial areas but were lower in urban backgrounds. Peak BTEX levels occurred during morning and evening rush hours, linked to traffic, heating, and atmospheric stagnation. B/T ratios ranged from 0.29 ± 0.11 to 1.35 ± 0.95, and X/E ratios ranged from 1.75 ± 0.91 to 3.68 ± 0.30, indicating primary pollution from local traffic, followed by solvents, coatings, and biomass burning. Lifetime cancer risk from BTEX exposure was below the definite risk threshold (10−4) but above the permissible risk level (10−6), suggesting moderate risk from benzene and ethylbenzene, particularly in traffic and industrial areas. Additionally, the health index of BTEX at monitoring sites was generally lower than the threshold limit value, suggesting a low non-carcinogenic risk overall. This study offers essential insights into BTEX pollution in urban European environments.

BTEX (benzene, toluene, ethylbenzene, m,p,o-xylene) are significant urban air pollutants. This study examines BTEX variability across seven European countries using data from 22 monitoring sites in different urban settings (urban background, traffic, industry, and suburban background). Results indicate that the relative abundance of BTEX in urban areas follows the order: toluene > benzene > m,p-xylene > o-xylene > ethylbenzene, with mean mixing ratios of 391 ± 451, 252 ± 324, 222 ± 297, 92 ± 119, and 78 ± 107 ppt from 2017 to 2022, respectively. Seasonal trends show benzene had similar median concentrations across urban background, traffic, and industrial sites, indicating mixed sources. Toluene levels were highest in traffic and industrial areas, highlighting road traffic and industrial emissions. Ethylbenzene and xylenes showed equivalent levels in traffic and industrial areas but were lower in urban backgrounds. Peak BTEX levels occurred during morning and evening rush hours, linked to traffic, heating, and atmospheric stagnation. B/T ratios ranged from 0.29 ± 0.11 to 1.35 ± 0.95, and X/E ratios ranged from 1.75 ± 0.91 to 3.68 ± 0.30, indicating primary pollution from local traffic, followed by solvents, coatings, and biomass burning. Lifetime Cancer Risk (LCR) values for BTEX exposure were below the definite risk threshold (10−4) but above the permissible risk level (10−6), suggesting moderate risk from benzene and ethylbenzene, particularly in traffic and industrial areas. This study offers essential insights into BTEX pollution in European urban environments.

Phosphatidylinositol 3-kinase α, a heterodimer of catalytic p110α and one of five regulatory subunits, mediates insulin- and insulin like growth factor-signaling and, frequently, oncogenesis. Cellular levels of the regulatory p85α subunit are tightly controlled by regulated proteasomal degradation. In adipose tissue and growth plates, failure of K48-linked p85α ubiquitination causes diabetes, lipodystrophy and dwarfism in mice, as in humans with SHORT syndrome. Here we elucidated the structures of the key ubiquitin ligase complexes regulating p85α availability. Specificity is provided by the substrate receptor KBTBD2, which recruits p85α to the cullin3-RING E3 ubiquitin ligase (CRL3). CRL3 forms multimers, which disassemble into dimers upon substrate binding (CRL3 -p85α) and/or neddylation by the activator NEDD8 (CRL3 ~N8), leading to p85α ubiquitination and degradation. Deactivation involves dissociation of NEDD8 mediated by the COP9 signalosome and displacement of KBTBD2 by the inhibitor CAND1. The hereby identified structural basis of p85α regulation opens the way to better understanding disturbances of glucose regulation, growth and cancer.

Nat. Biotechnol. 35, 969–976 (2017); published online 18 September 2017; corrected after print 28 February 2018 In the version of this article initially published, in the HTML, the wrong Creative Commons Attribution license (cc-by-nc rather than cc-by) was inserted. The error has been corrected in the HTML version of the article.